Mitigating Glycemic Disparities: Understanding Contributions of Sociodemographic Variables in the Teamwork, Targets,

Ananta Addala1, Victor Ritter2, Blake Shaw2

  • 1Department of Pediatrics, Division of Pediatric Endocrinology, Stanford University, Stanford, CA; Stanford Diabetes Research Center, Stanford University, Stanford, CA.

Insights

Early continuous glucose monitoring (CGM) in youth with type 1 diabetes (T1D) improved glycemic outcomes and reduced disparities. The Teamwork, Targets, Technology, and Tight Glycemia (4T) program showed effectiveness in addressing sociodemographic barriers.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Technology
  • Health Equity

Background:

  • Type 1 diabetes (T1D) management in youth requires addressing sociodemographic factors to reduce health disparities.
  • Continuous Glucose Monitoring (CGM) offers potential for improved glycemic control but access and support vary.
  • The Teamwork, Targets, Technology, and Tight Glycemia (4T) program was designed to integrate CGM with support for new-onset T1D.

Purpose of the Study:

  • To evaluate if early CGM initiation with programmatic support in youth with T1D reduces glycemic disparities.
  • To assess the impact of the 4T program on Hemoglobin A1c (HbA1c) levels across different sociodemographic groups.
  • To identify key factors contributing to glycemic variability in pediatric T1D.

Main Methods:

  • A prospective study involving new-onset T1D youth initiated on CGM within one month of diagnosis.
  • Evaluation of HbA1c levels at 12 months, stratified by race/ethnicity, insurance, deprivation, and language.
  • Comparison of outcomes across three cohorts: historical, pilot, and study 1, spanning from 2014 to 2022.

Main Results:

  • In study 1, HbA1c levels were lowest among non-Hispanic White youth, those with low deprivation, private insurance, and English preference.
  • Disparities in HbA1c by ethnicity and insurance were attenuated in study 1 compared to historical cohorts.
  • Socioeconomic deprivation and race/ethnicity were the largest contributors to HbA1c variability (41.3% and 32.2%, respectively).

Conclusions:

  • The 4T program, incorporating early CGM and support, improved glycemic outcomes and reduced disparities, particularly by insurance and ethnicity.
  • Socioeconomic deprivation emerged as a significant factor influencing HbA1c variability and a target for future interventions.
  • The 4T program demonstrates potential as an effective, equity-oriented model for managing pediatric T1D.
Abstract

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This phenomenon...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...